MD — what changed in the latest 10-Q
A section-by-section comparison of MD's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-04 vs the prior 10-Q · 2026-05-05
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +37 | −24 | ~11 | 11 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 0 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 3 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | 0 | −1 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-04
In addition, attempts to limit federal and state spending continue on GHC Programs by limiting or reducing Medicare and Medicaid reimbursement for various services. Medicare pays physicians for their services using a formula that multiplies a standard dollar amount (called the conversion factor) by …
Transformational and restructuring expenses (net of tax of $3,349 and $2,610)
A blended tax rate of 25% was used to calculate the tax effects of the adjustments for the six months ended June 30, 2026 and 2025.
Three Months Ended June 30, 2026 as Compared to Three Months Ended June 30, 2025
Our net revenue was $487.8 million for the three months ended June 30, 2026, as compared to $468.8 million for the same period in 2025. The increase in net revenue of $19.0 million, or 4.0%, was primarily attributable to an increase in non-same unit activity, primarily from the impact of recent acqu…
Text removed vs the prior filing · source: 10-Q · 2026-05-05
Three Months Ended March 31, 2026 as Compared to Three Months Ended March 31, 2025
Our net revenue was $476.2 million for the three months ended March 31, 2026, as compared to $458.4 million for the same period in 2025. The increase in net revenue of $17.8 million, or 3.9%, was primarily attributable to an increase in same-unit revenue and to a lesser extent, non-same unit activit…
Practice salaries and benefits increased $8.7 million, or 2.6%, to $345.7 million for the three months ended March 31, 2026, as compared to $337.0 million for the same period in 2025. The increase of $8.7 million was primarily attributable to an increase in clinical compensation expense at our exist…
Practice supplies and other operating expenses decreased $1.2 million, or 6.4%, to $17.5 million for the three months ended March 31, 2026, as compared to $18.7 million for the same period in 2025. The decrease was primarily attributable to non-same unit activity, primarily resulting from practice d…
General and administrative expenses primarily include all billing and collection functions and all other salaries, benefits, supplies and operating expenses not specifically related to the day-to-day operations of our affiliated physician practices and services. General and administrative expenses w…
Other information
Text removed vs the prior filing · source: 10-Q · 2026-05-05
On May 1, 2026, the Company and Ms. Mary Ann E. Moore, the Executive Vice President, General Counsel, Chief Administrative Officer and Secretary of the Company, determined that Ms. Moore would transition from her role at the Company, after 20 years as a leader of our organization. The transition is …
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice